Female Reproductive System Reconstructive Procedures DRG Reimbursement

Studies of perioperative techniques and surgical approaches for complex pelvic reconstructive procedures: randomized or cohort studies comparing different surgical approaches (e.g., native tissue repair versus use of grafts or meshes, laparoscopic/robotic-assisted versus open techniques) in women undergoing reconstructive surgery for pelvic organ prolapse, fistula repair, or extensive post-oncologic reconstruction. These trials enroll hospitalized patients requiring index inpatient procedures and focus on intraoperative outcomes, complication rates, and short-term recovery metrics, helping surgeons refine technique selection for specific anatomic defects and patient comorbidities. Results inform providers on best practices to reduce complications and length of stay and inform payers about procedure-related resource utilization and cost-effectiveness across competing surgical options.
Comparative effectiveness and enhanced recovery pathway studies assessing perioperative optimization and complication reduction: pragmatic trials or prospective cohorts evaluate multimodal prehabilitation, antibiotic/prophylaxis protocols, thromboprophylaxis strategies, and standardized enhanced recovery after surgery (ERAS) bundles in women undergoing reconstructive pelvic procedures. These studies target typical inpatient populations with varying age, BMI, prior pelvic surgery, or radiation exposure, measuring outcomes such as blood loss, transfusion need, infectious and wound complications, readmission rates, and timing of return to baseline function. Findings are relevant for clinicians to implement evidence-based perioperative protocols and for payers to understand how standardized pathways can lower complication-driven costs and improve discharge efficiency.
Longitudinal outcomes and quality-of-life studies focused on functional recovery and long-term sequelae after inpatient reconstructive procedures: observational cohorts and registry-based research follow patients for months to years after surgery to assess durable symptom relief, sexual and urinary function, recurrence of prolapse or fistula, late mesh- or graft-related issues, and need for reoperation. These studies enroll the diverse population treated under this DRG, including those with underlying oncologic resections, obstetric trauma, or congenital anomalies, and collect patient-reported outcomes alongside healthcare utilization data. This evidence helps providers counsel patients regarding expected long-term outcomes and helps payers evaluate lifetime costs and value (including reoperation rates and ongoing care needs) associated with different initial treatment strategies.

Studies of perioperative techniques and surgical approaches for complex pelvic reconstructive procedures: randomized or cohort studies comparing different surgical approaches (e.g., native tissue repair versus use of grafts or meshes, laparoscopic/robotic-assisted versus open techniques) in women undergoing reconstructive surgery for pelvic organ prolapse, fistula repair, or extensive post-oncologic reconstruction. These trials enroll hospitalized patients requiring index inpatient procedures and focus on intraoperative outcomes, complication rates, and short-term recovery metrics, helping surgeons refine technique selection for specific anatomic defects and patient comorbidities. Results inform providers on best practices to reduce complications and length of stay and inform payers about procedure-related resource utilization and cost-effectiveness across competing surgical options.
Comparative effectiveness and enhanced recovery pathway studies assessing perioperative optimization and complication reduction: pragmatic trials or prospective cohorts evaluate multimodal prehabilitation, antibiotic/prophylaxis protocols, thromboprophylaxis strategies, and standardized enhanced recovery after surgery (ERAS) bundles in women undergoing reconstructive pelvic procedures. These studies target typical inpatient populations with varying age, BMI, prior pelvic surgery, or radiation exposure, measuring outcomes such as blood loss, transfusion need, infectious and wound complications, readmission rates, and timing of return to baseline function. Findings are relevant for clinicians to implement evidence-based perioperative protocols and for payers to understand how standardized pathways can lower complication-driven costs and improve discharge efficiency.
Longitudinal outcomes and quality-of-life studies focused on functional recovery and long-term sequelae after inpatient reconstructive procedures: observational cohorts and registry-based research follow patients for months to years after surgery to assess durable symptom relief, sexual and urinary function, recurrence of prolapse or fistula, late mesh- or graft-related issues, and need for reoperation. These studies enroll the diverse population treated under this DRG, including those with underlying oncologic resections, obstetric trauma, or congenital anomalies, and collect patient-reported outcomes alongside healthcare utilization data. This evidence helps providers counsel patients regarding expected long-term outcomes and helps payers evaluate lifetime costs and value (including reoperation rates and ongoing care needs) associated with different initial treatment strategies.

OpenPayer

Summary & Overview

Female Reproductive System Reconstructive Procedures: Inpatient Reimbursement Overview

DRG 748 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes